Method of treating post menopausal osteoporosis with hexafluro-v

Details Method of treating post menopausal osteoporosis with hexafluro-v Method of treating post menopausal osteoporosis with hexafluro-v

1994-02-18

1996-11-05

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

514168, 552653, A61K 3159, A61K 31595

Patent

active

055718027

ABSTRACT:
A method of treating post menopausal osteoporosis which comprises administering to a subject having the disease an effective daily dose of 26,26,26,27,27,27-hexafluoro-1.alpha.,25-dihydroxycholecalciferol compound in an amount from about 0.05 .mu.g to about 2.0 .mu.g.

REFERENCES:
patent: 4248791 (1982-02-01), DeLuca et al.
patent: 4358406 (1982-11-01), DeLuca et al.
patent: 4411833 (1983-10-01), DeLuca et al.
"BioFactors; Vitamin D Research-First International Congress on Vitamins and Biofactors in Life Sciences", DeLuca et al, vol. 3, No. 4, pp. 271, Apr. 1992.
"Bone and Mineral; 26,27-Hexafluoro-1,25-Dihydroxyvitamin D.sub.3 (F6-1,25(OH).sub.2 D.sub.3) Prevents Osteoporosis Induced by Immobilization combined with Ovariectomy in the Rat", Okumura et al, vol. 9, No. 2, pp. 101-109, May 1990.
"Bone and Mineral; Biological Potency of a Fluorinated Vitamin D Analogue in Hypoparathyroidism", Nakatsuka et al, vol. 16, No. 1, pp. 73-81, Jan. 1992.
"Archives of Biochemistry and Biophysics; 26,26,26,27,27,27-Hexafluoro-1,25-Dihydroxyvitamin D.sub.3 : A Highly Potent, Long-Lasting Analog of 1,25-Dihydroxyvitamin D.sub.3 ", Tanaka et al, vol. 229, No. 1, pp. 348-354, 1984.
Tilyard, Murray W. et al., "Treatment of Postmenopausal Osteoporosis With Calcitrol or Calcium", The New England Journal of Medicine, vol. 326, No. 6, pp. 357-362 (1992).
Aloia, John F., M.D. et al, "Calcitrol in the Treatment of Postmenopausal Osteoporosis", The American Journal of Medicine, vol. 84, pp. 401-408 (1988).

Affiliated with

Also associated with

Rating

Method of treating post menopausal osteoporosis with hexafluro-v does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating post menopausal osteoporosis with hexafluro-v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating post menopausal osteoporosis with hexafluro-v will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2015308